anecortave acetate has been researched along with Neovascularization, Optic Disc in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murakami, T; Nukada, M; Ogino, K; Unoki, N; Yoshimura, N | 1 |
| Joussen, AM; Kirchhof, B | 1 |
| Eandi, CM; Freund, KB; Klais, CM; Ober, MD; Sadeghi, SN; Slakter, JS; Sorenson, JA; Spaide, RF; Yannuzzi, LA | 1 |
| Eandi, CM; Freund, KB; Klais, CM; Ober, MD; Slakter, JS; Sorenson, JA; Yannuzzi, LA | 1 |
| Arnold, J; Hunyor, A; Karacorlu, M; Kelly, S; Wilson, D | 1 |
| Clark, AF; Collier, RJ; Penn, JS; Rajaratnam, VS | 1 |
2 trial(s) available for anecortave acetate and Neovascularization, Optic Disc
| Article | Year |
|---|---|
Anecortave acetate treatment for retinal angiomatous proliferation: a pilot study.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Angiomatosis; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Injections; Intraocular Pressure; Macular Degeneration; Male; Pilot Projects; Pregnadienediols; Prospective Studies; Retinal Neovascularization; Retinal Vessels; Tomography, Optical Coherence; Visual Acuity | 2006 |
Anecortave acetate for the treatment of idiopathic perifoveal telangiectasia: a pilot study.
Topics: Adult; Aged; Angiogenesis Inhibitors; Capillary Permeability; Female; Fluorescein Angiography; Fovea Centralis; Humans; Male; Middle Aged; Pilot Projects; Pregnadienediols; Prospective Studies; Retinal Neovascularization; Retinal Vessels; Telangiectasis; Treatment Outcome; Visual Acuity | 2006 |
4 other study(ies) available for anecortave acetate and Neovascularization, Optic Disc
| Article | Year |
|---|---|
Time-lapse imaging of retinal angiogenesis reveals decreased development and progression of neovascular sprouting by anecortave desacetate.
Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Chemokine CXCL12; Diagnostic Imaging; Disease Models, Animal; Dose-Response Relationship, Drug; Fluorescent Antibody Technique, Indirect; Mice; Mice, Inbred C57BL; Microscopy, Electron; Organ Culture Techniques; Pregnadienediols; Retinal Neovascularization; Retinal Vessels; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2010 |
[Angiogenesis in ophthalmology. A theme with a future].
Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Agents; Choroidal Neovascularization; Corneal Neovascularization; Diabetic Retinopathy; Endothelial Growth Factors; Eye Diseases; Humans; Infant, Newborn; Intercellular Signaling Peptides and Proteins; Lymphokines; Macular Degeneration; Metalloendopeptidases; Neovascularization, Pathologic; Organic Chemicals; Platelet-Derived Growth Factor; Pregnadienediols; Retinal Neovascularization; Retinopathy of Prematurity; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Diagnostic and therapeutic challenges.
Topics: Adult; Angiogenesis Inhibitors; Combined Modality Therapy; Epiretinal Membrane; Female; Fluorescein Angiography; Hemangioblastoma; Humans; Laser Coagulation; Macular Edema; Neoplasm Recurrence, Local; Pregnadienediols; Retinal Neoplasms; Retinal Neovascularization; Vision Disorders; Visual Acuity; von Hippel-Lindau Disease | 2007 |
The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity.
Topics: Angiogenesis Inhibitors; Animals; Animals, Newborn; Blotting, Northern; Disease Models, Animal; Female; Humans; Infant, Newborn; Injections; Male; Nuclease Protection Assays; Plasminogen Activator Inhibitor 1; Pregnadienediols; Random Allocation; Rats; Rats, Sprague-Dawley; Retinal Neovascularization; Retinopathy of Prematurity; RNA Probes; RNA, Messenger; Vitreous Body | 2001 |